We studied the expression of MDM2 protein and p53 protein in 67 cases
of the breast carcinoma. The result demonstrated no significant relati
onship between the MDM2 protein expression and any of the clinicopatho
logical parameters except for the estrogen receptor status (p=0.033).
Furthermore, in p53 protein negative cases, there was a significant re
lationship between MDM2 protein expression and the ER status (p=0.027)
. This study showed the expression of ER to be associated with MDM2 pr
otein in p53 protein negative breast carcinoma. These results thus sug
gested that an investigation of both p53 and MDM2 gene alteration reve
aled precise information regarding breast carcinoma.